Sonoma Pharmaceuticals appoints Chad White as CFO, succeeding Jerry Dvonch effective Nov 18, 2022

Sonoma Pharmaceuticals, Inc.

Jerry Dvonch resigns as CFO effective Nov 18, 2022; will assist transition to Boulder, CO office by Dec 31.
Chad White appointed interim CFO Oct 3 and permanent CFO Nov 18; previously CFO at Slumber Cloud and Outlast Technologies.
White receives $230,000 annual salary, bonus up to 50% of salary, and options for 5,000 shares vesting over 3 years.
Company closing Woodstock, GA office; operations to be centralized in Boulder, CO.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Chad White

Chief Financial Officer

SNOA · Sonoma Pharmaceuticals, Inc.

Effective: 2022-10-03
Filed: October 7, 2022, 7:59 PM ET

Effective on October 3, 2022, our Board of Directors appointed Chad White as our interim Chief Financial Officer.

Departed

Jerry Dvonch

Chief Financial Officer

SNOA · Sonoma Pharmaceuticals, Inc.

Effective: 2022-11-18
Successor: Chad White
Filed: October 7, 2022, 7:59 PM ET

We accepted the resignation of Mr. Dvonch as Chief Financial Officer effective November 18, 2022.

Role change

Chad White

Chief Financial Officer

SNOA · Sonoma Pharmaceuticals, Inc.

Effective: 2022-11-18
Filed: October 7, 2022, 7:59 PM ET

Effective November 18, 2022, Mr. White will serve as Chief Financial Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Chad White was appointed as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Effective on October 3, 2022, our Board of Directors appointed Chad White as our interim Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jerry Dvonch resigned as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

We accepted the resignation of Mr. Dvonch as Chief Financial Officer effective November 18, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.8

Chad White changed role as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..

Role: Chief Financial Officer

Exact text from the filing

Effective November 18, 2022, Mr. White will serve as Chief Financial Officer of the Company.

View on SEC.gov

Sonoma Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-22-006801

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.